Science
How China Raced Ahead of the U.S. on Nuclear Power
China is quickly becoming the global leader in nuclear power, with nearly as many reactors under construction as the rest of the world combined. While its dominance of solar panels and electric vehicles is well known, China is also building nuclear plants at an extraordinary pace. By 2030, China’s nuclear capacity is set to surpass that of the United States, the first country to split atoms to make electricity.
Many of China’s reactors are derived from American and French designs, yet China has overcome the construction delays and cost overruns that have bogged down Western efforts to expand nuclear power.
At the same time, China is pushing the envelope, making breakthroughs in next-generation nuclear technologies that have eluded the West. The country is also investing heavily in fusion, a potentially limitless source of clean power if anyone can figure out how to tame it.
Beijing’s ultimate objective is to become a supplier of nuclear power to the world, joining the rare few nations — including the United States, Russia, France and South Korea — that can design and export some of the most sophisticated machines ever invented.
“The Chinese are moving very, very fast,” said Mark Hibbs, a senior fellow at the Carnegie Endowment for Peace who has written a book on China’s nuclear program. “They are very keen to show the world that their program is unstoppable.”
As the United States and China compete for global supremacy, energy has become a geopolitical battleground. The United States, particularly under President Trump, has positioned itself as the leading supplier of fossil fuels like oil, gas and coal. China, by contrast, dominates the manufacturing of solar panels, wind turbines and batteries, seeing renewable power as the multi-trillion-dollar market of the future.
Nuclear power is enjoying a resurgence of global interest, especially as concerns about climate change mount. That’s because nuclear reactors don’t spew planet-warming emissions, unlike coal and gas plants, and can produce electricity around the clock, unlike wind and solar power.
The Trump administration wants to quadruple U.S. nuclear power capacity by 2050, even as it ignores global warming, and it hopes to develop a new generation of reactor technology to power data centers at home and sell to energy-hungry countries overseas. Officials fear that if China dominates the nuclear export market, it could expand its global influence, since building nuclear plants abroad creates deep, decades-long relationships between countries.
Yet in the race for atomic energy, China has one clear advantage: It has figured out how to produce reactors relatively quickly and cheaply. The country now assembles reactors in just five to six years, twice as fast as Western nations.
While U.S. nuclear construction costs skyrocketed after the 1960s, they fell by half in China during the 2000s and have since stabilized, according to data published recently in Nature. (The only two U.S. reactors built this century, at the Vogtle nuclear plant in Waynesboro, Ga., took 11 years and cost $35 billion.)
Construction costs of nuclear reactors
“When we first got this data and saw that declining trend in China, it surprised me,” said Shangwei Liu, a research fellow at the Harvard Kennedy School of Government who led the paper.
The big questions, Mr. Liu said, are how China got so good at nuclear power — and whether the United States can catch up.
How China mastered nuclear power
A modern nuclear power plant is one of the most complex construction projects on Earth.
The reactor vessel, where atoms are split, is made of specialized steel up to 10 inches thick that must withstand bombardment by radiation for decades. That vessel, in turn, is housed in a massive containment dome, often three stories high and about as wide as the U.S. Capitol dome, made of steel-reinforced concrete to prevent dangerous leaks. Thousands of miles of piping and wiring must meet exacting safety standards.
Financing these multibillion-dollar projects is staggeringly difficult. Even minor problems, like needing regulator approval to modify a component midway through, can lead to long delays and can cause borrowing costs to skyrocket.
Over time, China has conquered this process.
It starts with heavy government support. Three state-owned nuclear developers receive cheap government-backed loans to build new reactors, which is valuable since financing can be one-third of costs. The Chinese government also requires electric grid operators to buy some of the power from nuclear plants at favorable rates.
Just as importantly, China’s nuclear companies build only a handful of reactor types and they do it over and over again.
That allows developers to perfect the construction process and is “essential for scaling efficiently,” said Joy Jiang, an energy innovation analyst at the Breakthrough Institute, a pro-nuclear research organization. “It means you can streamline licensing and simplify your supply chain.”
The fact that the Chinese government has a national mandate to expand nuclear power means that companies can confidently invest in domestic factories and a dedicated engineering work force. In a sprawling complex near Shanghai, giant reactor pressure vessels are being continuously forged, ready to be shipped to new projects without delay. Teams of specialized welders move seamlessly from one construction site to the next.
It’s been different in the West.
In the 1970s and 1980s, U.S. nuclear construction slowed to a trickle as interest rates rose and regulators frequently tightened safety rules, causing delays. Worries about the disposal of nuclear waste and fears after the 1979 partial meltdown of a reactor at Three Mile Island, in Pennsylvania, didn’t help. At the same time, private developers kept experimenting with new reactor designs that required different components and introduced fresh complications. U.S. nuclear power died from a lack of predictability.
The contrast became glaring in the late 2000s, when U.S. utilities tried to revive nuclear power with a new reactor model called the AP1000, with improved safety features. Developers struggled with the novel technology, leading to repeated delays and soaring costs. By the time the two reactors in Georgia were finished last year, most utilities were hesitant to try again.
As it happened, China built AP1000s at the same time. It, too, faced severe challenges, such as difficulties in obtaining coolant pumps and unpredictable cost spikes. But instead of giving up, Chinese officials studied what went wrong and concluded they needed to tweak the design and develop domestic supply chains.
“What the Chinese did was really smart,” said James Krellenstein, the chief executive of Alva Energy, a nuclear consultancy. “They said, we’re going to pause for a few years and incorporate every lesson learned.”
China is now building nine more copies of that reactor, known as the CAP1000, all on pace to be completed within five years at a drastically lower cost, an Energy Department report found.
At the Haiyang nuclear power plant, China keeps building
Nuclear proponents in the United States sometimes argue that overly strict safety regulations drive up costs.
China’s safety requirements are similar. But in China the approval process is more predictable, and opponents have fewer ways to challenge a project. Most reactors in China break ground weeks after receiving final approval from the safety regulator, according to research by Ms. Jiang. In the United States, by contrast, projects often need additional permits from state governments that can take months or years.
“China is practiced at building really big things, everything from dams to highways to high speed rail, and those project management skills are transferable,” said David Fishman, a power sector consultant at Lantau Group, a consulting firm.
As China, the world’s biggest emitter of greenhouse gases, seeks to curb pollution, it is counting on nuclear power to play an important role.
Solar and wind power are growing fast and account for most of China’s clean electricity, but the country also burns enormous amounts of coal to supply power when the sun isn’t shining and the wind isn’t blowing. More nuclear power could help backstop renewables and displace coal.
China’s nuclear expansion still faces hurdles. One of China’s plants suffered a smaller radioactive leak in 2021, and a bigger accident could trigger a public backlash. The country is still figuring out where to bury its nuclear waste, and some cities have seen impassioned protests over plans for waste reprocessing plants. Beijing has also blocked new reactors in much of China’s interior over concerns about their water use. If that moratorium persists, it could limit the industry’s growth.
For now, though, the country is barreling ahead, with plans to build hundreds of reactors by midcentury.
Can the U.S. catch up?
In the United States, nuclear power is one of the rare types of energy that has support from Republican and Democratic politicians alike, especially as demand for electricity rises. Even environmentalists like Al Gore who once fretted about catastrophic accidents and radioactive waste are warming to the technology.
Yet the U.S. is pursuing a starkly different path to nuclear expansion, one that leans more heavily on private innovation than government backing.
Dozens of start-ups are working on a new generation of smaller reactors meant to be cheaper than the hulking plants of old. Tech companies like Google, Amazon and OpenAI are pouring billions into nuclear start-ups like Kairos Power, X-Energy and Oklo to help power their data centers for artificial intelligence. Early projects are underway in Wyoming, Texas and Tennessee, though few, if any, new reactors are expected before the 2030s.
The Trump administration wants to accelerate this work by reducing regulations at the Nuclear Regulatory Commission, which certifies the safety of reactors before they are built. The agency’s critics say it has become too hidebound to handle advanced reactors that are less prone to meltdowns.
Energy Secretary Chris Wright said that the administration is betting that the private capital flowing into nuclear projects will spark American ingenuity and catapult the U.S. ahead of China. “Entrepreneurial capitalist competition is where the U.S. thrives, and I think it’s an advantage over China,” he said in an interview.
Yet some worry that the United States is betting too heavily on technological breakthroughs instead of focusing on the financing, skills and infrastructure needed to build plants, as China has. The U.S., for instance, has lost almost all of its heavy forging capacity to make large reactor components. A new generation of advanced reactors could also take years to perfect, leaving America behind.
“You look at the number of designs, particularly in the U.S., you think, Oh, God, help us,” said Philip Andrews-Speed, a senior research fellow at the Oxford Institute for Energy Studies. “I would think narrowing down is the sensible thing to do.”
While the Trump administration has moved to speed up nuclear permitting and increase domestic supplies of nuclear fuel, some important government tools for advancing new reactors, such as the Energy Department’s loan office, have been hampered by staffing cuts. Efforts to slash safety regulations could be contentious. There is also a risk that interest by tech giants could fizzle if the A.I. boom slows.
“There’s no reason the United States couldn’t expand nuclear power,” said Stephen Ezell, vice president for global innovation policy at the Information Technology and Innovation Foundation. “But are we just going to see a few small reactors power a few data centers, or are we going to see a serious whole government approach to bring back nuclear power as an essential source of electricity?”
A race to power the world
China’s fast-paced nuclear program is a prelude to a larger goal: dominating the global market. Chinese companies have already built six reactors in Pakistan and plan to export many more.
At the same time, China is working to surpass the United States in technological innovation. China has built what it calls the world’s first “fourth generation” reactor, a gas-cooled model that can provide heat and steam for heavy industry in addition to electricity. The Chinese are also pursuing technologies that use less uranium, such as thorium reactors, or recycle spent nuclear fuel. It’s a recognition that China doesn’t have enough domestic uranium for a massive build-out of traditional reactors.
Even if U.S. companies and labs remain at the forefront of innovation, one recent report warned that China was 10 to 15 years ahead of the United States in its ability to deploy next-generation reactors widely.
It’s a familiar story: The United States invented solar panels and batteries, only to watch as China scaled those technologies and now controls global markets.
“Maybe we can convince some of our allies not to buy Chinese reactors, but there are going to be plenty of other countries out there with growing energy demands,” said Paul Saunders, president of the Center for National Interest, a conservative-leaning think tank. “And if America isn’t ready, we won’t be able to compete.”
Science
Video: Pentagon Releases U.F.O. Files
new video loaded: Pentagon Releases U.F.O. Files
By Jorge Mitssunaga
May 8, 2026
Science
Trump Plans to Fire F.D.A. Commissioner Marty Makary
President Trump has signed off on a plan to fire Dr. Marty Makary, commissioner of the Food and Drug Administration, after a series of clashes over vaping, oversight of the abortion pill and a series of new drug application denials that rattled biotech companies, according to a person briefed on the matter, who was not authorized to discuss it publicly.
Dr. Makary had a high profile for an F.D.A. commissioner, appearing frequently on television and podcasts to sell the work he was doing at the agency on improving the food supply, speeding up some drug approvals and trying to restore agency morale after thousands of staff members left.
He tried to walk the tightrope between the business-friendly Make America Great Again movement, pledging to get rid of regulations that slow down innovation and to attract more drug trials to the United States. He was an ally of Health Secretary Robert F. Kennedy Jr.’s Make American Healthy Again supporters, voicing the skepticism of the pharmaceutical industry and authorizing natural food dyes.
Ultimately, Dr. Makary’s efforts were not enough to overcome the grievances of a growing band of enemies focused on selling tobacco, opposing abortion and seeing biotech therapies authorized.
Mr. Trump’s decision to dismiss him was first reported by The Wall Street Journal.
The decision could still change, given Mr. Trump’s propensity to change his mind Dr. Makary has also proven persuasive with Mr. Trump in beating back previous efforts to oust him.
Leaving the White House Friday evening, Mr. Trump dismissed the idea that Dr. Makary would be fired.
“I’ve been reading about it, but I know nothing about it,” he said.
The White House has pressured Dr. Makary for months to authorize flavored e-cigarettes, according to a person close to the conversations. The approvals were a top wish of major tobacco companies that have been top donors to Mr. Trump. In March, the F.D.A. issued a memo saying that it would only authorize e-cigarettes in flavors such as mint, tea and spices. The memo said the fruit and candy flavors would be unlikely to pass muster, given their appeal to young people.
Pressure continued, though, and on Tuesday the F.D.A. authorized blueberry and mango flavored e-cigarettes by Glas, a small company based in Los Angeles.
Abortion foes including Susan B. Anthony Pro-Life America have continued to turn up the heat on Dr. Makary, reiterating their call for his firing on Thursday. The group’s leaders and others view Dr. Makary as dragging his feet on a safety review of the abortion pill mifepristone, which they viewed as a way to highlight what they believe are dangers of the drug. Former Vice President Mike Pence, who also opposes abortion rights, amplified criticism of Dr. Makary on social media as well.
The administration has been under pressure from conservatives to tighten regulations on the prescribing and dispensing of mifepristone. The Supreme Court is reviewing a federal appeals court ruling that temporarily blocked abortion providers from prescribing the drug through telemedicine and sending it to patients by mail.
Biotech companies and their investors have also raised alarms with the White House about agency decisions to reject a series of treatments for rare diseases. The F.D.A. typically turns down about 20 percent of the applications it receives for drug approvals from companies.
Dr. Makary has been aggressive in defending the decisions, which he said came from career scientists who found the medications ineffective.
Dr. Makary also had to contend with a health secretary who seemed to view the F.D.A. as an avenue for getting his favored products authorized, exemplified by Mr. Kennedy’s social media post saying that the agency would end its “war on” stem cell treatments, peptides and raw milk. Mr. Kennedy pushed the F.D.A. to reverse a 2023 ban and allow the use of a number of peptides, unproven compounds purported to offer anti-aging or muscle-recovery benefits.
Before leading the F.D.A., Dr. Makary was a cancer surgeon and health policy researcher at Johns Hopkins University School of Medicine. He was also the author of several books about the health care system.
Some of Dr. Makary’s more popular moves included encouraging broader use of hormone replacement products for women and lifting the F.D.A.’s warnings on them. He helped speed some promising drugs to market, including a pancreatic cancer therapy and the pill form of the popular GLP-1 weight loss drugs.
Science
Californians were aboard hantavirus-stricken cruise ship. Is there a risk to the public?
Some California residents were among the 147 passengers and staff aboard a luxury cruise ship stricken by a suspected outbreak of hantavirus that has left three people dead and several others severely ill, officials confirmed Thursday.
California public health officials say they are monitoring the situation after being notified by the U.S. Centers for Disease Control and Prevention that some state residents were passengers on the MV Hondius. The precise status of those individuals, however, remains murky.
Hantavirus is a rare but deadly disease that attacks the lungs and is typically contracted by humans through inhalation of particles contaminated with the urine, feces or saliva of a wild rodent.
However, Dr. Tedros Adhanom Ghebreyesus, director-general of the World Health Organization, confirmed Thursday that the Andes virus — a form of hantavirus that can spread from person to person — was involved in the outbreak.
Here’s what we know:
The MV Hondius cruise ship anchored at a port in Praia, Cape Verde, on Wednesday.
(Misper Apawu / Associated Press)
As its name suggests, the Andes virus is typically found in South America. The Dutch-flagged MV Hondius was on a 46-day journey that traveled from Antarctica with stops in Argentina.
In the case of human-to-human transmission, a person would first be infected by a wild rodent’s contaminated particles and then pass the infection to someone else, said Dr. Gaby Frank, director of the Johns Hopkins Special Pathogens Center.
“In previous outbreaks of Andes virus, transmission between people has been associated with close and prolonged contact, particularly among household members, intimate partners and people providing medical care,” Ghebreyesus said. “That appears to be the case in the current situation.”
None of the remaining passengers or crew members on the ship are symptomatic, he said.
The ship was not permitted to allow passengers to disembark at its original destination, Cape Verde, and is sailing for Spain’s Canary Islands.
“I want to be unequivocal here: This is not SARS-CoV-2. This is not the start of a COVID pandemic. This is an outbreak that we see on a ship. There’s a confined area,” Dr. Maria Van Kerkhove, who leads the WHO’s epidemic and pandemic management, said at a briefing. “This is not the same situation we were in six years ago. It doesn’t spread the same way like coronaviruses do.”
California passengers on the cruise
On April 1, 114 guests boarded the cruise ship in Ushuaia, Argentina. Twenty-three days later, 30 passengers — including six people from the United States — disembarked on a stop in St. Helena, a remote island about 1,100 miles off the coast of Africa, according to the cruise operator Oceanwide Expeditions.
Public health agencies in California, Georgia and Arizona were notified by the CDC that some of their residents were among the passengers on the cruise. It’s unclear whether these individuals disembarked on April 24, however.
The CDC is assisting local health authorities with monitoring California residents who were aboard the cruise, according to a statement by the California Department of Public Health on Friday.
As of Friday, one passenger has returned to their California residence and is in contact with local public health officials, and at least one other remains aboard the ship, according to the state agency.
“We understand that news of an unusual outbreak can be concerning,” said Dr. Erica Pan, director of the California Department of Public Health. “Unlike influenza and COVID-19, years of experience in South America have shown that this Andes hantavirus rarely spreads between people.”
Officials said the current public health protocol is to do daily symptom monitoring and reporting.
“As there are no known cases of Andes hantavirus infection from people without symptoms, and any spread has usually been limited to people with prolonged close contact with an ill person with this virus, the risk to the general public in California is extremely low,” the agency said in a statement.
In a statement earlier this week, the CDC also said that the risk to the American public “is extremely low” at this time.
“We urge all Americans aboard the ship to follow the guidance of health officials as we work to bring you home safely,” the agency said.
The others who exited the ship on April 24 were individuals from Canada, Denmark, Germany, the Netherlands, New Zealand, Switzerland, Sweden, Singapore, St. Kitts and Nevis, Turkey and the United Kingdom.
Of the remaining passengers still aboard the ship headed for Spain’s Canary Islands, California Department of Public Health said none were ill as of Friday.
How many people have been infected?
The number of lab-confirmed hantavirus cases has risen to five, according to the WHO. There are three additional suspected cases.
A timeline of reported cases of hantavirus aboard the cruise ship can be found here.
The WHO is monitoring reports of other people with symptoms “who may have had contact with one of the passengers. In each case, we are in close contact with the relevant authorities,” Tedros said.
The first passenger to have been infected, a Dutchman, became sick aboard the cruise ship on April 6 and died on April 11.
No samples were taken, because his symptoms were similar to other respiratory diseases. His widow left the ship with his body on April 24 during the scheduled stop at St. Helena.
“She deteriorated during a flight to Johannesburg on the 25th of April and died the next day,” Tedros said.
Before boarding the cruise ship, the Dutch couple had traveled through Argentina, Chile and Uruguay on a bird-watching trip, “which included visits to sites where the species of rat that is known to carry Andes virus was present,” Tedros said.
After leaving the ship, the woman was briefly aboard a KLM aircraft in Johannesburg bound for Amsterdam but was barred from the flight due to her medical condition, the airline said in a statement.
Dutch news outlets reported that a flight attendant on a KLM airplane — who briefly had contact with the widow — started feeling sick and had mild symptoms and was in isolation at a hospital in Amsterdam.
The flight attendant has since tested negative for the Andes virus, Dr. Jeremy Faust, an emergency medicine physician, wrote on his Substack blog, Inside Medicine, citing a text message sent to him by Tedros.
“It is still possible that the flight attendant contracted the Andes virus. However, given our understanding of the virus, this information means that the flight attendant’s symptoms are not caused by the Andes hantavirus, but by some other medical illness,” Faust wrote.
More cases may be reported, because the incubation period — the time it takes between exposure to the virus and the onset of illness — for the Andes strain of the hantavirus is up to six weeks.
What we know about hantavirus
There are roughly 50 identified species of hantavirus. The virus that’s found in the Americas tends to cause a cardiopulmonary syndrome, a condition that affects the heart and the lungs, according to Frank.
There have been 890 laboratory-confirmed cases of hantavirus disease reported in the U.S. since surveillance began in 1993, according to the most recent data from the CDC.
From 1980 to 2025, 99 California residents have been diagnosed with a hantavirus infection, according to the California Department of Public Health.
CDC officials said 38% of people who develop respiratory symptoms may die from the disease.
Still, the data suggest that contracting hantavirus is rare, said Dr. Afif El-Hasan, member of the American Lung Assn.’s national board of directors.
There is no vaccine or specific antiviral medicine for hantavirius.
Intensive-care treatment may include intubation and oxygen therapy, fluid replacement and use of medications to lower blood pressure, according to the American Lung Assn.
The signs of hantavirus
Early symptoms of hantavirus are similar to the flu and include fatigue, fever and muscle aches, according to the CDC. Symptoms start to develop within one to eight weeks after contact with an infected rodent.
Half of those who contract the virus also experience headaches, dizziness, chills, nausea, vomiting, diarrhea and abdominal pain.
Four to 10 days after the initial phase of the illness, another round of symptoms can develop, which include coughing, shortness of breath and possible tightness in the chest as the lungs fill with fluid.
Even though contracting hantavirus in the U.S. continues to be a rare event, El-Hasan said, people should take these initial symptoms seriously and promptly seek medical care.
How to protect yourself
Hantavirus cases can occur year-round, but the peak seasons in the United States are the spring and summer, which coincide with the reproductive seasons for deer mice.
To lessen your risk of infection, keep wild rodents out of your home and other enclosed spaces by sealing any holes and placing snap traps.
If you find evidence of mice, wear personal protective equipment and disinfect the area. When you’re done, put everything, including cleaning materials, in a bag and toss it in your trash bin.
-
Detroit, MI1 minute agoDetroit Tigers lose fifth straight, Kerry Carpenter injured
-
San Francisco, CA13 minutes agoFallen tree downs powerlines in SF, delays Muni line
-
Dallas, TX19 minutes agoFC Dallas vs Real Salt Lake: Lineup notes 📝
-
Miami, FL25 minutes agoYour 2026 Miami Dolphins Draft Picks Expectations
-
Boston, MA31 minutes ago
Texas A&M SS Boston Kellner suffers orbital bone fracture
-
Denver, CO37 minutes agoPedestrian fatally hit by Frontier airplane departing Denver for Los Angeles, flight canceled after
-
Seattle, WA43 minutes agoSeattle beer garden employee found fatally shot inside business
-
San Diego, CA49 minutes agoDel Mar enacts new attendance rules for board, commission, committee members